Your browser doesn't support javascript.
loading
A case of cisplatin-refractory advanced pure seminoma showing complete remission after treatment with high-dose carboplatin plus etoposide as fourth-line salvage chemotherapy.
Tachikawa, Kimihito; Nishiyama, Naotaka; Muranaka, Takashi; Takada, Koichi; Murase, Kazuyuki; Kouno, Tsutomu; Junji, Kato; Masumori, Naoya.
Afiliación
  • Tachikawa K; 1Department of Urology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido 060-8543 Japan.
  • Nishiyama N; 1Department of Urology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido 060-8543 Japan.
  • Muranaka T; 1Department of Urology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido 060-8543 Japan.
  • Takada K; 2Departments of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Murase K; 2Departments of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kouno T; Department of Medical Oncology, Sasaki Foundation Kyoundo Hospital, Tokyo, Japan.
  • Junji K; 2Departments of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Masumori N; 1Department of Urology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido 060-8543 Japan.
Int Cancer Conf J ; 7(1): 6-10, 2018 Jan.
Article en En | MEDLINE | ID: mdl-31149504
We report the case of a patient who achieved complete remission (CR) of cisplatin-refractory metastatic pure seminoma after treatment with high-dose carboplatin and etoposide (CE) with peripheral blood stem cell transplantation as fourth-line chemotherapy. A 38-year-old man was diagnosed with advanced pure seminoma (pT3N3M1aS3). In the international germ cell consensus classification, his prognosis was classified as intermediate. He was treated with high-dose CE as fourth-line chemotherapy after treatment with BEP, VeIP, and TIN. After two cycles of high-dose CE, the concentrations of T-HCG and other tumor markers showed normal levels. A CT scan and PET-CT showed that the lymph node swelling had disappeared and there was no uptake. The CR has continued for 27 months after the treatment. High-dose CE might be less toxic and have a better prognostic outcome than other treatments as salvage chemotherapy for patients with cisplatin-refractory advanced testicular cancer.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Int Cancer Conf J Año: 2018 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Int Cancer Conf J Año: 2018 Tipo del documento: Article